Prostatype Genomics publishes year-end report for 2023
Prostatype Genomics AB today publishes its year-end report for the full year 2023, including the interim report for the second half of 2023. The full year-end report is attached and can also be downloaded from the company’s website, www.prostatypegenomics.com.Summary of the second half of the year and the full year 2023 Second half of 2023, 1 July 2023 – 31 December 2023• Net sales amounted to 908 TSEK (414)• EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to -17,797 TSEK (-14,849)• Cash flow from current operations amounted to -9,938 TSEK (-16,386)